Success Stories: A Pakistani Clinical Research Coordinator in Biomedical Sciences Secures I-140 NIW Approval in Just 1 Month and 17 Days with the Premium Processing

 

Client’s Testimonial:

“This is great news! I cannot thank your team enough for this superb work on my case, with everything being so detailed!”


On May 12th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical Research Coordinator-Intermediate in the Field of Biomedical Sciences (Approval Notice).


General Field: Biomedical Sciences

Position at the Time of Case Filing: Clinical Research Coordinator-Intermediate

Country of Origin: Pakistan

State of Residence at the Time of Filing: Michigan

Approval Notice Date: May 12th, 2025

Processing Time: 1 month and 17 days (Premium Processing requested)


Case Summary:

A Clinical Research Coordinator from Pakistan, specializing in biomedical sciences, approached our firm for assistance with his I-140 National Interest Waiver (NIW) petition. After reviewing his qualifications, which included a strong publication record and significant contributions to the field, we were confident in his eligibility. The petition was approved in just 1 month and 17 days with the premium processing, reflecting both the client's exceptional qualifications and the strength of the case we presented.

Proposed Endeavor: Advancing Disease Research and Treatment Strategies

Our client’s proposed work in the U.S. will focus on advancing disease prevention and treatment strategies, particularly in the areas of inflammatory bowel and heart disease, Heart Disease, autoimmune disorders, and novel infections of significant healthcare burden.. His research aims to address critical areas of unmet patient needs and improve clinical outcomes for these pressing health issues. His work directly aligns with U.S. national interests in biotechnologies, machine learning, and AI, and his findings will contribute to enhancing clinical outcomes by optimizing and synthesizing predictive, therapeutic, and diagnostic modalities.

Notable Achievements Supporting the Petition

To support his NIW petition, we highlighted the following key achievements:

● A substantial publication record with 42 peer-reviewed journal articles (14 first-authored), 53 conference abstracts (7 first-authored) in reputable journals, showcasing his expertise in clinical research

● 1,050 citations across his work, with many articles ranked among the top 10% most cited in their respective years

● Active peer reviewer with at least 83 reviews for top journals, showcasing his significance in the field

● Research supported by NIH, the National Institute of Diabetes and Digestive and Kidney Diseases

● Editorial board member and guest editor for various high-impact scientific journals pertinent to his field.

I-140 NIW Approved in Just 1 Month and 17 Days

We are proud to report that the client’s I-140 NIW petition was approved in just 1 month and 17 days with the premium processing. This success was achieved without any Request for Evidence [RFE]. This quick approval reflects his strong qualifications and the timely, impactful nature of his work in biomedical sciences. We are excited about his future contributions to advancing medical research and patient care in the United States.